Navigation Links
Radiology advance points way to non-invasive brain-cancer treatment

Glioblastoma Multiforme, GBM, is a brain cancer death sentence.

Of the approximately 12,000 people who are diagnosed with GBM annually in the U.S., half will die within a year, and the rest within 3 years. The only treatments that stretch survival limits are exceptionally invasive surgeries to remove the tumor and radiation treatment with the maximum tolerated dose - all of which leads to......

Full article >>> y cell death, gadolinium atoms must be localized in the nuclei of cancer cells."

Because of the deadly nature of GBM, De Stasio says an alternative is desperately needed to current therapies. De Stasio says it will be a year before it is known whether the treatment works in animal models, and likely another five to ten years before any clinical trials and available treatments would emerg......

Full article >>>
'"/>

Source:wistechnology.com By John Morgan 01/02/06


Related biology technology :

1. Quintessence Biosciences advances cancer drug
2. Rockwells $1M gift to UWM will support advanced automation research
3. Healthcare slow to adopt genetic advances
4. Nano-diamond film studied at UW could advance telecommunications
5. Doyle says practical politics must advance embryonic stem cell research
6. Madison biotech introduces drug discovery advance
7. FDA approves advanced digital mammography system
8. Wireless advances in Madison, heats up in Waukesha
9. 55 advance in business plan contest
10. Imago microscope leads to Northwestern research advance
11. GE Healthcares CT Scanner advances coronary imaging
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... to announce that Biohaven has issued today the following ... (PRWEB) Dec 9, 2016 - Biohaven Pharmaceutical ... that the U.S. Food and Drug Administration ("FDA") has ... drug candidate BHV-0223, an orally dissolving tablet being developed ...
(Date:12/8/2016)... Medical Incorporated ("OncoSec") (NASDAQ: ONCS ), ... announced financial results for the fiscal first quarter ... our commitment to address an unmet medical need ... with the early clinical response data presented from ... on advancing our lead program – ImmunoPulse® IL-12 ...
(Date:12/8/2016)... Eurofins announces the appointment of Sean Murray , National Division ... Mr. Murray will bring valuable expertise to the ... leading international business teams. As the National Division Leader, he will ... status as the global leader in bio-analytical testing services. ... , , ...
(Date:12/8/2016)... Dec. 8, 2016  Anaconda BioMed S.L., a pre-clinical ... the next generation neuro-thrombectomy system for the treatment of ... G. Jovin, MD to join its Scientific Advisory Board ... strategic network of scientific and clinical experts to Anaconda ... the ANCD BRAIN ® to its clinical phase. ...
Breaking Biology Technology:
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology ... object recognition technologies, today announced that the MegaMatcher ... cards was submitted for the NIST Minutiae ... passed all the mandatory steps of the evaluation ... is a continuing test of fingerprint templates used ...
(Date:11/16/2016)... CLARA, Calif. , Nov. 16, 2016 ... enhancing user experience and security for consumer electronics, ... for the financial and retail industry, today announced ... secure and convenient way to authenticate users of ... uses Sensory,s TrulySecure™ software which requires ...
(Date:11/14/2016)... Nov. 14, 2016  Based on its ... Frost & Sullivan recognizes FST Biometrics with ... for Visionary Innovation Leadership. FST Biometrics emerged ... identification market by pioneering In Motion Identification ... instant, seamless, and non-invasive verification. This patented ...
Breaking Biology News(10 mins):